Right Heartwise Secures Prestigious EIC Transition Grant to Advance Cardiovascular Innovation
Right Heartwise Secures Prestigious EIC Transition Grant to Advance Cardiovascular Innovation
Embedded Files
Right Heartwise has been awarded the highly competitive EIC Transition Grant, marking a significant milestone in our journey to revolutionize cardiovascular care. This prestigious funding from the European Innovation Council (EIC) will accelerate the development of our groundbreaking motorless, patient-specific heart pump, designed to offer a life-saving solution for patients with right heart failure.
A Major Step Toward Transforming Cardiovascular Care
The EIC Transition Grant is awarded to innovative startups and research-driven companies with disruptive technologies poised for commercialization. With this support, Heartwise will further refine its biofluidic and patient-centric approach, conduct advanced testing, and move closer to clinical validation.
What’s Next for Right Heartwise?
With this funding, we will:
✅ Advance prototype development to enhance performance and biocompatibility.
✅ Expand preclinical studies to validate the effectiveness of our heart pump.
✅ Strengthen collaborations with key research institutions and industry leaders.
✅ Lay the groundwork for regulatory approval and market entry.
Selected as a Deep Tech Pioneer at Hello Tomorrow Global Challenge
Out of 4,600 applications from 120 countries, Right HeartWise distinguished itself as a leading light in deep tech. As a Deep Tech Pioneer, Right HeartWise will gain exclusive, year-round access to a wealth of opportunities within Hello Tomorrow's dynamic community.
Taking place on the 13th and 14th March 2025, the Hello Tomorrow Global Summit is an annual event bringing thousands of attendees to the forefront of new ideas, uncovering the most promising new projects across all industries.
The Hello Tomorrow Global Summit is the closing event of the Deep Tech Days, which is a week-long gathering in Paris made up of events dedicated to celebrating and accelerating deep tech innovation: connecting key people bringing solutions from lab to market and strengthening the deep tech investment network. The flagship events include: the Hello Tomorrow Investor Day, Financing the Future and the Global Summit.
KWORKS'24 DEMODAY
After 9 months of training and hard work at KWORKS - Koç University Entrepreneurship Research Center we had the incredible opportunity to present Right Heartwise to a room full of investors and industry experts at our demo day.
It was truly inspiring to see so many innovative ideas come to life and to be a part of such a supportive ecosystem. Grateful for this journey and excited for what’s next! 🚀
Co-Founders: Kerem Pekkan TANSU GÖLCEZ Canberk Yıldırım Kagan Ucak
Thanks to Clinical Team: Kadir Caliskan Professor Osama Soliman, MD, PhD Sakir Akin Erhan Tenekecioglu Goksel Guven
You can watch the presentation from here: (Language is Turkish)
Time: 1:28:25
📣Webinar Announcement 📣
Join us on October 17th for an insightful ESAO European Society for Artificial Organs session with Prof. Kerem Pekkan where he'll present our latest research on "Patient-Specific Right-Ventricle Assist Devices Without External Power".
Right heart failure is an increasing concern, with approximately 35% of patients using LVAD developing right heart failure due to the non-physiological compatibility of existing devices. To address this, we’ve developed algorithms that automatically generate patient-specific VAD designs. With advances in 3D printing, our goal is to become pioneers in delivering tailored VADs to significantly improve patient outcomes and quality of life. This will be a game-changer for those facing right ventricular failure!
Don't miss this chance to discover the future of patient-specific VAD technology and how our innovative solutions can transform lives.
Page updated
Google Sites
Report abuse